BIOCRYST PHARMACEUTICALS INC (34) | Business Finance (8)

Browse by Subcategory

Recent Contracts

THIRD aMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT (Filed With SEC on November 6, 2020)
Form of Warrant to Purchase Common Stock, dated June 1, 2020 (Filed With SEC on June 1, 2020)
Underwriting Agreement, dated May 27, 2020, by and among BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the... (Filed With SEC on June 1, 2020)
BioCryst Pharmaceuticals, Inc. Employee Stock Purchase Plan (as amended and restated as of March 19, 2020) (Filed With SEC on May 13, 2020)
Securities Purchase Agreement, dated November 19, 2019, among BioCryst Pharmaceuticals, Inc., Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on November 20, 2019)
Description of Common Stock (Filed With SEC on March 13, 2020)
Form of Warrant to Purchase Common Stock, dated November 21, 2019 (Filed With SEC on November 21, 2019)
Underwriting Agreement, dated November 13, 2019, by and between BioCryst Pharmaceuticals, Inc. and J.P. Morgan Securities LLC, as representative of the underwriters named in... (Filed With SEC on November 18, 2019)